Cutler Group LP Chembio Diagnostics, Inc. Call Options Transaction History

Cutler Group LP

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 04, 2022	SELL	$0.45 - $0.8 $90 - $160	-200 Reduced 40.0%	300 $0
Q1 2022 Apr 14, 2022	SELL	$0.66 - $1.23 $3,366 - $6,273	-5,100 Reduced 91.07%	500 $0
Q4 2021 Jan 18, 2022	SELL	$1.09 - $2.55 $16,241 - $37,995	-14,900 Reduced 72.68%	5,600 $0
Q3 2021 Oct 26, 2021	BUY	$2.06 - $5.34 $40,582 - $105,198	19,700 Added 2462.5%	20,500 $2,000
Q2 2021 Jul 19, 2021	SELL	$2.88 - $5.64 $1,728 - $3,384	-600 Reduced 42.86%	800 $0
Q1 2021 Apr 26, 2021	SELL	$3.4 - $7.97 $27,880 - $65,354	-8,200 Reduced 85.42%	1,400 $0
Q4 2020 Jan 21, 2021	SELL	$4.11 - $7.51 $16,029 - $29,289	-3,900 Reduced 28.89%	9,600 $3,000
Q3 2020 Oct 27, 2020	SELL	$3.28 - $5.93 $15,088 - $27,278	-4,600 Reduced 25.41%	13,500 $8,000
Q2 2020 Jul 22, 2020	BUY	$3.18 - $15.54 $57,558 - $281,274	18,100 New	18,100 $4,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.